These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 178354)

  • 21. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
    Whitson RH; Appleman MM
    Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of a 5.3-S calmodulin-deficient 3':5'-cyclic nucleotide phosphodiesterase from cardiac muscle.
    Mohindru A; Rhoads AR
    Biochem J; 1982 Aug; 205(2):427-35. PubMed ID: 6291508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
    Onali P; Schwartz JP; Hanbauer I; Costa E
    Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher-plant cyclic nucleotide phosphodiesterases. Resolution, partial purification and properties of three phosphodiesterases from potato tuber.
    Ashton AR; Polya GM
    Biochem J; 1975 Aug; 149(2):329-39. PubMed ID: 241333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
    Thompson WJ; Ross CP; Pledger WJ; Strada SJ; Banner RL; Hersh EM
    J Biol Chem; 1976 Aug; 251(16):4922-9. PubMed ID: 182685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW; Kuo JF
    Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose.
    Klee CB; Krinks MH
    Biochemistry; 1978 Jan; 17(1):120-6. PubMed ID: 201280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial purification and characterization of cyclic nucleotide phosphodiesterases from human bronchial tissue.
    Bergstrand H; Lundquist B
    Mol Cell Biochem; 1978 Oct; 21(1):9-15. PubMed ID: 215899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
    Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A
    Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182
    [No Abstract]   [Full Text] [Related]  

  • 35. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
    Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate and effector specificity of a guanosine 3':5'-monophosphate phosphodiesterase from rat liver.
    Moss J; Manganiello VC; Vaughan M
    J Biol Chem; 1977 Aug; 252(15):5211-5. PubMed ID: 195942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic nucleotide phosphodiesterases in uterine development.
    Stancel GM; Thompson WJ; Strada SJ
    Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of cyclic nucleotide phosphodiesterases from rat brain by activator protein, proteolytic enzymes and a vitamin E derivative.
    Sakai T; Yamanaka H; Tanaka R; Makino H; Kasai H
    Biochim Biophys Acta; 1977 Jul; 483(1):121-34. PubMed ID: 195621
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification of a Ca2+-activatable cyclic nucleotide phosphodiesterase from bovine heart by specific interaction with its Ca2+-dependent modulator protein.
    Ho HC; Wirch E; Stevens FC; Wang JH
    J Biol Chem; 1977 Jan; 252(1):43-50. PubMed ID: 188813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.